SlideShare a Scribd company logo
The longest-lasting,
most popular
(and yet most thoroughly discredited)
idea
in the history of
modern public policy
Jeremy A. Lauer, PhD
Economist
Economic Analysis and Evaluation
Health Systems Governance and Financing
Cost-effectiveness analysis
1. Identify CEA’s connections to social choice and
– enumerate the reasons explaining its durability.
2. Review the foundations of CEA and
– clarify points of confusion.
3. Articulate an account of generalized CEA that differs
from, and
– is more liberal than, the standard version.
4. Reconcile disputes between generalized and
incremental CEA, and
– explain the source of controversies around threshold-
based rules in decision-making.
5. Link the theory of generalized CEA to real-world
decision making in a novel way.
What I said I would do
“The rapid and continuing growth of expenditures is a central
issue in many policy decisions concerning the medical care
system .... Policymakers, health professionals, and consumers
are seeking ways to control this growth while simultaneously
improving the quality of health care. Increasingly, the use of
cost-effectiveness analysis ... is being advocated...”
United States Congress Office of Technology Assessment. The Implications of Cost-
Effectiveness Analysis of Medical Technology, Washington, DC, 1980.
How to begin an article, 1980
“It has become increasingly popular to carry out cost-
effectiveness analyses in economic evaluations of healthcare
programmes.”
Karlsson G, Johannesson M. The decision rules of cost-effectiveness analysis.
Pharmacoeconomics. 1996 Feb;9(2):113-20.
How to begin an article, 1993
“An increasing number of health-care systems, both public
and private, such as managed-care organizations, are adopting
results from cost-effectiveness analysis as one of the
measures to inform decisions on allocation of health-care
resources.”
Eichler HG, Kong SX, Gerth WC, Mavros P, Jönsson B. Use of cost-effectiveness analysis
in health-care resource allocation decision-making: how are cost-effectiveness
thresholds expected to emerge? Value Health, 7(5):518-28, 2004.
How to begin an article, 2004
“… cost-effectiveness analysis (CEA) studies ... are routinely used
around the globe to inform priority setting in health care and public
health....”
Cookson R, Mirelman AJ, Griffin S, Asaria M, Dawkins B, Norheim OF, Verguet S, J Culyer A.
Using Cost-Effectiveness Analysis to Address Health Equity Concerns. Value Health,
20(2):206-212, 2017.
How to begin an article, 2017
“…decisions about whether to adopt technologies and
services in publicly funded benefit packages, involve balancing
health gains against the costs of the required resources: more
and more frequently this is done in an explicit way, on the
basis of analyses that build upwards from the biomedical
evidence to create information to support decision makers in
coming to judgements about value for money.”
Lauer et al., in preparation, 2018
How to begin, again, 2018
1980
1993
2004
2017
2018
(and
so on)
What goes around is called a wheel
Perhaps this has an esoteric meaning
Or possibly it’s just a goldfish story*
*“It looks like new scenery,
every time!”
“I’m still where I was 40 years ago!”
In few fields of science can one claim:
Why is CEA so robust?
1. CEA expresses the idea that health is an
intrinsic benefit (i.e. it counts in its own
terms).
– Important distinction w.r.t. its main competitor,
benefit-cost analysis.
2. CEA is rational:
– It respects individual autonomy.
– It is objective (i.e. it uses scientific methods which
are subject to continual open-source review).
– It is impartial to persons.
Why is CEA so robust?
Two mainstreams in moral philosophy
• Kant: Deontological concerns about rules of action:
the stream MCDA is in.
• Sidgwick: Utilitarian consequentialism:
the stream CEA is in.
3. It belongs to a mainstream of moral
philosophy:
– the idea that actions should be judged by their
outcomes, or consequences, and
– that causal modelling can capture and organize
knowledge about the relevant states of the
world.
Why is CEA so robust?
4. CEA solves a “coordination problem”
– how do disparate groups of people organize
themselves around a particular action or set of
actions?
– In economics, also called the problem of vertical
integration.
Why is CEA so robust?
1. United States Congress Office of Technology Assessment. The Implications of
Cost-Effectiveness Analysis of Medical Technology, Washington, DC, 1980.
2. Drummond M, O’Brien B, Stoddart G, et al. Methods for the Economic
Evaluation of Health Care Programmes, Oxford University Press, 1987.
3. Canadian Coordinating Office for Health Technology Assessment. Guidelines
for economic evaluation of pharmaceuticals, Ottawa, Canada: Canadian
Coordinating Office for Health Technology Assessment, 1994.
4. Gold M, Siegel J, Russell L, et al. Cost-effectiveness in Health and Medicine.
New York & Oxford: Oxford University Press, 1996.
5. World Health Organization. Guide to Cost-Effectiveness Analysis, Geneva:
World Health Organization, 2003.
6. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied Methods of
Cost-effectiveness Analysis in Health Care, Oxford, 2011.
7. Wilkinson T, Sculpher MJ, Claxton K, et al. The International Decision Support
Initiative Reference Case for Economic Evaluation: An Aid to Thought. Value
Health, 2016; 19: 921-928.
Evolution is a fact
Cost-effectiveness analysis was developed and
refined in response to the demands of specific
settings:
– during the latter years
of the 20th century
– in the United States,
Canada and England
– [Refs 1, 2, 3, 4].
Beginnings matter
There was a perception, in those days, on the part
of decision makers, in those settings, that they had
a mandate to improve the health of populations:
through the regulation, financing or direct provision of
health services.
A la recherche du temps perdu…
The 1980 report of the “Office
of Technology Assessment of
the United States Congress”
cites over 650 references:
– applying economic analysis to healthcare,
– virtually all published in the 1970s, and
– a substantial minority of which were published by
government agencies.
The hard progress of experience
• In the early years of this century, staff at the
WHO became interested in the application of
cost-effectiveness analysis to health problems
in developing countries [Ref 5].
• Hundreds (if not thousands) of scientific
papers applying CEA to global health problems
have since been published.
New horizons
• The technical basis of CEA evolved to support the needs of
actors operating in a variety of jurisdictions.
• For example, generalized cost effectiveness analysis
(GCEA) was ostensibly created with the needs of lower
income countries in mind:
– not to solve the problem of the growing costs of medical care,
– but to prioritize essential services for under-served populations.
• Yet GCEA inevitably picked up themes from contemporary
debates, in particular, those about health maximization
and decision rules.
Changes in practice bring
changes in theory
• Birch S, Gafni A. Cost effectiveness/utility analyses.
Do current decision rules lead us to where we want
to be? J Health Econ. 1992 Oct; 11(3):279-96.
• Johannesson M, Weinstein MC. On the decision rules
of cost-effectiveness analysis. J Health Econ. 1993
Dec;12(4):459-67.
Do decision rules maximize health?
1. So-called generalized cost-effectiveness
analysis:
– based on health maximization
– (not thresholds).
2. So-called incremental (or marginal) cost-
effectiveness analysis:
– based on decision rules
– involving thresholds.
Two schools of thought
Generalized vs incremental
Generalized vs incremental
b1
GCEA: focus on portfolios
Starting points and portfolios matter*
*Acknowledgements to Richard Cookson for this clarification.
• Interest in obtaining value for money for
health in developing countries continues to
grow:
– the founding of the International Decision
Support Initiative [Ref 7], and
– the increasing use of CEA by a variety of domestic
stakeholders and decision makers in developing
and emerging economies.
Global health, no longer public health
• In the guidelines, over the years, CEA is given
various justifications, often based
on common sense principles.
• However, CEA contains a cryptic
sub-text, known only to a few…
• CEA’s gnostic doctrine comes
from duality theory for linear programming.
The hidden story of CEA
Weinstein and Zeckhauser, 1973.
• WZ introduced the powerful idea of
mathematical programming to CEA.
• WZ also made CEA’s first* giant strategic
blunder:
– anchoring the notion of critical ratios in the
mythology of CEA.
• This resulted in lasting harms:
– notably, controversies over ratio-centric cost-
effectiveness thresholds.
“No hay bien que por mal no venga”
(every silver lining brings its cloud)
*The second giant mistake was arguably the (self-defeating) “CHOICE GDP thresholds”.
Weinstein and Zeckhauser, 1973.
• CEA was not pre-destined to have a ratio-centric
theory:
– nothing pre-determined about this,
– witness the many book-length guidelines.
• CEA could equally have been developed around
the concept of net benefit analysis, net cost
analysis or even just opportunity cost analysis.
• The latter is arguably the fundamental concept of
CEA, not critical ratios.
Different possible pasts for CEA
1. Lagrangian constrained optimization.
2. Duality theory in linear programming.
• For our purposes, they’re the same:
– Both involve optimal E/C ratios.
• Because convex optimization, KKT theory, and
mathematical programming are the primary
superstructure of modern mathematical economics,
we’ll use the latter form of the problem (duality).
There are two sources of critical ratios
The formulation of WZ is that of the primal of
the linear-programming “knapsack problem”.
The critical ratio comes from the dual
of the knapsack problem
(N.B. There’s no critical ratio in the primal knapsack
problem.)
Two great ideas that go great together
The combination of:
– Linear programming (e.g. the simplex method of 1947,
without critical ratios), and
– Duality for linear programming, with critical ratios).
• These ideas go so well together that they usually
come pre-mixed:
Once you’ve seen it, you can’t unsee it
Duality is hard
(From the Preface to Nering ED, Tucker AW. Linear Programming and
Related Problems. Boston, MA: Academic Press, 1993.)
• Informal communications from George Dantzig:
– Duality for linear programming conjectured by John
von Neumann.
– Proved by Albert Tucker, post-WWII at Princeton:
• Some standard sources on duality are:
– Dantzig et al., 1956
– Luenberger, 1973;
– Nering and Tucker, 1993
– Bertsekas, 1995.
Duality is new
• Weinstein and Zeckhauser, 1973.
• On the glass-half-full view, without WZ:
– health economics would probably still be called
medical economics, and
– we’d possibly still be doing cost of illness studies, à
la Dorothy Rice.
• COI/CBA being the larger part of what
predated the emergence of CEA in health
economics.
Duality is contemporary to the
codification of CEA
1. Focus on optimal portfolios (WHO-CHOICE).
2. Redefine thresholds (York CHE).
Two possible resolutions to CEA’s
critical ratio problem
York approach
What's in, what's out : designing benefits for universal health coverage
edited by Amanda Glassman, Ursula Giedion, and Peter C. Smith.
• Are a summary measure of opportunity cost.
• Are a measure of the marginal productivity of
the health system.
• Are a shortcut that avoids the need to
quantify the costs and benefits of all feasible
interventions.
• Are a measure of the health people forgo
when other options are funded than the ones
that would benefit them.
York thresholds are not ratios - they:
CHOICE approach:
efficient allocation doesn’t need ratios
(There are no critical ratios in the primal knapsack.)
Optimal portfolio of
activities
CVD
Cancers
Respiratory
Conditions
Diabetes
Current portfolio of
activities
CVD
Cancers
Respiratory
Conditions
Diabetes
“Magical rationalist” view of Efficient Allocation
“Presto, change-o!”
Current portfolio Optimal portfolio
Health system factors
Politics
Affordability
“Dismal realist” view of Efficient Allocation
We may never
get there…
• A given optimal portfolio requires a particular type of
health system, with a particular set of fixed assets.
• Information about the contents of the portfolio allows
actors in the health system to coordinate their choices.
• Human resources and facilities, and logistics and supply
networks, are fixed assets that are not replaceable,
transferable or created in the short term.
• Information about the optimal portfolio should
influence most decisions about asset-specific
investments.
• This is one of the meanings of priority setting –
determining which asset-specific investments to make.
CHOICE view of Efficient Allocation
Two kinds of decision-making
(N.B. they are not strongly method dependent)
• Localized, or incremental, decision-making:
– Starts from current situation and adds things one at a time,
– Often uses a threshold (of some kind).
• Strategic, context-setting, decision-making:
– Looks at many things at once, including the current
portfolio,
– Usually employs explicit maximization; sometimes uses a
threshold.
• When CEA is used to support localized decisions, we
term it incremental cost-effectiveness analysis (ICEA).
• When CEA is used to support strategic decisions, we
call it generalized cost-effectiveness analysis (GCEA).
The longest-lasting, most popular, and yet most thoroughly discredited idea in the history of modern public policy: cost-effectiveness analysis

More Related Content

What's hot

Advancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health CareAdvancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health Care
The Commonwealth Fund
 
A Value Proposition for Creating Crowdfunding Research Platform for Integrati...
A Value Proposition for Creating Crowdfunding Research Platform for Integrati...A Value Proposition for Creating Crowdfunding Research Platform for Integrati...
A Value Proposition for Creating Crowdfunding Research Platform for Integrati...
Joanne Sienko Ott, CFA, MA
 
Matching ecohealth and One Health attributes for emerging infectious diseases...
Matching ecohealth and One Health attributes for emerging infectious diseases...Matching ecohealth and One Health attributes for emerging infectious diseases...
Matching ecohealth and One Health attributes for emerging infectious diseases...
ILRI
 
International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)
inventionjournals
 
ICU Health Economics
ICU Health Economics ICU Health Economics
ICU Health Economics
SMACC Conference
 
Cost utility analysis
Cost utility analysisCost utility analysis
Cost utility analysis
ARUNAYESUDAS
 
MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...
MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...
MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...Frank Fortin
 
health insurance in germany and indonesia
health insurance in germany and indonesiahealth insurance in germany and indonesia
health insurance in germany and indonesia
nivtrip
 
The Link between Health Condition Costs and Standard of Living Through Out-of...
The Link between Health Condition Costs and Standard of Living Through Out-of...The Link between Health Condition Costs and Standard of Living Through Out-of...
The Link between Health Condition Costs and Standard of Living Through Out-of...
Economic Research Forum
 
TheAffordableCareActFundingforPrimaryCareProviders
TheAffordableCareActFundingforPrimaryCareProvidersTheAffordableCareActFundingforPrimaryCareProviders
TheAffordableCareActFundingforPrimaryCareProvidersJonathan Brouse
 
Crimson Publishers-Future Medical Research Challenges
Crimson Publishers-Future Medical Research ChallengesCrimson Publishers-Future Medical Research Challenges
Crimson Publishers-Future Medical Research Challenges
CrimsonpublishersMedical
 
Kevin patrick calit2
Kevin patrick calit2Kevin patrick calit2
Kevin patrick calit23GDR
 
2 why did you decide to pursue a baccalaureate degree in nursin
2 why did you decide to pursue a baccalaureate degree in nursin2 why did you decide to pursue a baccalaureate degree in nursin
2 why did you decide to pursue a baccalaureate degree in nursin
AASTHA76
 
Managing Healthcare- Teja Mysore
Managing Healthcare- Teja MysoreManaging Healthcare- Teja Mysore
Managing Healthcare- Teja Mysorestejum
 
Acs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader ContextAcs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader Contextmedbookonline
 
1 1 abstract—with the advent of the technologic
1 1  abstract—with the advent of the technologic1 1  abstract—with the advent of the technologic
1 1 abstract—with the advent of the technologic
abhi353063
 
Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...
Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...
Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...
Borwornsom Leerapan
 
Overdiagnosis. astana 2018
Overdiagnosis. astana 2018Overdiagnosis. astana 2018
Overdiagnosis. astana 2018
CarmenFernndezAguila
 
Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1
Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1
Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1
Mondher Daghfous
 

What's hot (20)

Advancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health CareAdvancing Research to Reduce Low-value Health Care
Advancing Research to Reduce Low-value Health Care
 
A Value Proposition for Creating Crowdfunding Research Platform for Integrati...
A Value Proposition for Creating Crowdfunding Research Platform for Integrati...A Value Proposition for Creating Crowdfunding Research Platform for Integrati...
A Value Proposition for Creating Crowdfunding Research Platform for Integrati...
 
Matching ecohealth and One Health attributes for emerging infectious diseases...
Matching ecohealth and One Health attributes for emerging infectious diseases...Matching ecohealth and One Health attributes for emerging infectious diseases...
Matching ecohealth and One Health attributes for emerging infectious diseases...
 
International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)International Journal of Business and Management Invention (IJBMI)
International Journal of Business and Management Invention (IJBMI)
 
ICU Health Economics
ICU Health Economics ICU Health Economics
ICU Health Economics
 
Cost utility analysis
Cost utility analysisCost utility analysis
Cost utility analysis
 
MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...
MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...
MMS State of the State Conference: Elliott Fisher - Rethinking Health Care - ...
 
health insurance in germany and indonesia
health insurance in germany and indonesiahealth insurance in germany and indonesia
health insurance in germany and indonesia
 
The Link between Health Condition Costs and Standard of Living Through Out-of...
The Link between Health Condition Costs and Standard of Living Through Out-of...The Link between Health Condition Costs and Standard of Living Through Out-of...
The Link between Health Condition Costs and Standard of Living Through Out-of...
 
TheAffordableCareActFundingforPrimaryCareProviders
TheAffordableCareActFundingforPrimaryCareProvidersTheAffordableCareActFundingforPrimaryCareProviders
TheAffordableCareActFundingforPrimaryCareProviders
 
Crimson Publishers-Future Medical Research Challenges
Crimson Publishers-Future Medical Research ChallengesCrimson Publishers-Future Medical Research Challenges
Crimson Publishers-Future Medical Research Challenges
 
Kevin patrick calit2
Kevin patrick calit2Kevin patrick calit2
Kevin patrick calit2
 
2 why did you decide to pursue a baccalaureate degree in nursin
2 why did you decide to pursue a baccalaureate degree in nursin2 why did you decide to pursue a baccalaureate degree in nursin
2 why did you decide to pursue a baccalaureate degree in nursin
 
Managing Healthcare- Teja Mysore
Managing Healthcare- Teja MysoreManaging Healthcare- Teja Mysore
Managing Healthcare- Teja Mysore
 
Advancing-OSHMS High-Performance WS in OHM
Advancing-OSHMS High-Performance WS in OHMAdvancing-OSHMS High-Performance WS in OHM
Advancing-OSHMS High-Performance WS in OHM
 
Acs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader ContextAcs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader Context
 
1 1 abstract—with the advent of the technologic
1 1  abstract—with the advent of the technologic1 1  abstract—with the advent of the technologic
1 1 abstract—with the advent of the technologic
 
Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...
Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...
Strengthening Health Systems: Lessons Learned from 2nd Decade of Thailand’s U...
 
Overdiagnosis. astana 2018
Overdiagnosis. astana 2018Overdiagnosis. astana 2018
Overdiagnosis. astana 2018
 
Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1
Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1
Healthimpactassessment benharris-roxas-150610073811-lva1-app6892-1
 

Similar to The longest-lasting, most popular, and yet most thoroughly discredited idea in the history of modern public policy: cost-effectiveness analysis

3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
tamicawaysmith
 
Meaningful engagement of decision makers in priority-setting
Meaningful engagement of decision makers in priority-settingMeaningful engagement of decision makers in priority-setting
Meaningful engagement of decision makers in priority-settingCochrane.Collaboration
 
Medical Governance, Health Policy, and Health Sector Reform in the Philippines
Medical Governance, Health Policy, and Health Sector Reform in the PhilippinesMedical Governance, Health Policy, and Health Sector Reform in the Philippines
Medical Governance, Health Policy, and Health Sector Reform in the Philippines
Albert Domingo
 
Cortese/Korsmo Presentation
Cortese/Korsmo PresentationCortese/Korsmo Presentation
Cortese/Korsmo Presentation
Lee Aase
 
Accomplishing Reform Successful Case Studies Drawn From The Health Systems O...
Accomplishing Reform  Successful Case Studies Drawn From The Health Systems O...Accomplishing Reform  Successful Case Studies Drawn From The Health Systems O...
Accomplishing Reform Successful Case Studies Drawn From The Health Systems O...
Carrie Tran
 
Health Economics In Clinical Trials - Pubrica
Health Economics In Clinical Trials  - PubricaHealth Economics In Clinical Trials  - Pubrica
Health Economics In Clinical Trials - Pubrica
pubrica101
 
Value based healthcare 2020
Value based healthcare 2020Value based healthcare 2020
Value based healthcare 2020
Future Agenda
 
HeadnoteGovernments with universal healthcare systems are increa.docx
HeadnoteGovernments with universal healthcare systems are increa.docxHeadnoteGovernments with universal healthcare systems are increa.docx
HeadnoteGovernments with universal healthcare systems are increa.docx
isaachwrensch
 
Allocating resources for healthcare.pptx
Allocating resources for healthcare.pptxAllocating resources for healthcare.pptx
Allocating resources for healthcare.pptx
KeirelEdrin
 
Florida State UniversityCollege of Nursing and Health Sciences.docx
Florida State UniversityCollege of Nursing and Health Sciences.docxFlorida State UniversityCollege of Nursing and Health Sciences.docx
Florida State UniversityCollege of Nursing and Health Sciences.docx
AKHIL969626
 
Achieving Health Care Reform in the United States Toward a Whole-System Und...
Achieving Health Care Reform in the United States   Toward a Whole-System Und...Achieving Health Care Reform in the United States   Toward a Whole-System Und...
Achieving Health Care Reform in the United States Toward a Whole-System Und...
Suzanne Simmons
 
Design Research and Healthcare Reform - Mayo Clinic Proceedings
Design Research and Healthcare Reform - Mayo Clinic ProceedingsDesign Research and Healthcare Reform - Mayo Clinic Proceedings
Design Research and Healthcare Reform - Mayo Clinic Proceedings
Christine Chastain
 
The future of healthcare 2019
The future of healthcare 2019The future of healthcare 2019
The future of healthcare 2019
Future Agenda
 
Week 9 AssignmentContinue on with building your final applicatio.docx
Week 9 AssignmentContinue on with building your final applicatio.docxWeek 9 AssignmentContinue on with building your final applicatio.docx
Week 9 AssignmentContinue on with building your final applicatio.docx
philipnelson29183
 
Shared innovations in measurement and evaluation
Shared innovations in measurement and evaluationShared innovations in measurement and evaluation
Shared innovations in measurement and evaluationbikandob
 
Learning Health Care Systems
Learning Health Care SystemsLearning Health Care Systems
Learning Health Care Systems
Group Health Cooperative
 
Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1
Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1
Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1
Dipesh Tikhatri
 
National Juxtapositions in Healthcare Delivery and Quality
National Juxtapositionsin Healthcare Delivery and QualityNational Juxtapositionsin Healthcare Delivery and Quality
National Juxtapositions in Healthcare Delivery and Quality
Eric Luellen
 
Introduction to health economics for the medical practitioner
Introduction to health economics for the medical practitionerIntroduction to health economics for the medical practitioner
Introduction to health economics for the medical practitioner
Dr Matt Boente MD
 
The American Health Care Crisis - The Only Answer
The American Health Care Crisis - The Only AnswerThe American Health Care Crisis - The Only Answer
The American Health Care Crisis - The Only Answer
Roger H Strube MD (retired)
 

Similar to The longest-lasting, most popular, and yet most thoroughly discredited idea in the history of modern public policy: cost-effectiveness analysis (20)

3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
 
Meaningful engagement of decision makers in priority-setting
Meaningful engagement of decision makers in priority-settingMeaningful engagement of decision makers in priority-setting
Meaningful engagement of decision makers in priority-setting
 
Medical Governance, Health Policy, and Health Sector Reform in the Philippines
Medical Governance, Health Policy, and Health Sector Reform in the PhilippinesMedical Governance, Health Policy, and Health Sector Reform in the Philippines
Medical Governance, Health Policy, and Health Sector Reform in the Philippines
 
Cortese/Korsmo Presentation
Cortese/Korsmo PresentationCortese/Korsmo Presentation
Cortese/Korsmo Presentation
 
Accomplishing Reform Successful Case Studies Drawn From The Health Systems O...
Accomplishing Reform  Successful Case Studies Drawn From The Health Systems O...Accomplishing Reform  Successful Case Studies Drawn From The Health Systems O...
Accomplishing Reform Successful Case Studies Drawn From The Health Systems O...
 
Health Economics In Clinical Trials - Pubrica
Health Economics In Clinical Trials  - PubricaHealth Economics In Clinical Trials  - Pubrica
Health Economics In Clinical Trials - Pubrica
 
Value based healthcare 2020
Value based healthcare 2020Value based healthcare 2020
Value based healthcare 2020
 
HeadnoteGovernments with universal healthcare systems are increa.docx
HeadnoteGovernments with universal healthcare systems are increa.docxHeadnoteGovernments with universal healthcare systems are increa.docx
HeadnoteGovernments with universal healthcare systems are increa.docx
 
Allocating resources for healthcare.pptx
Allocating resources for healthcare.pptxAllocating resources for healthcare.pptx
Allocating resources for healthcare.pptx
 
Florida State UniversityCollege of Nursing and Health Sciences.docx
Florida State UniversityCollege of Nursing and Health Sciences.docxFlorida State UniversityCollege of Nursing and Health Sciences.docx
Florida State UniversityCollege of Nursing and Health Sciences.docx
 
Achieving Health Care Reform in the United States Toward a Whole-System Und...
Achieving Health Care Reform in the United States   Toward a Whole-System Und...Achieving Health Care Reform in the United States   Toward a Whole-System Und...
Achieving Health Care Reform in the United States Toward a Whole-System Und...
 
Design Research and Healthcare Reform - Mayo Clinic Proceedings
Design Research and Healthcare Reform - Mayo Clinic ProceedingsDesign Research and Healthcare Reform - Mayo Clinic Proceedings
Design Research and Healthcare Reform - Mayo Clinic Proceedings
 
The future of healthcare 2019
The future of healthcare 2019The future of healthcare 2019
The future of healthcare 2019
 
Week 9 AssignmentContinue on with building your final applicatio.docx
Week 9 AssignmentContinue on with building your final applicatio.docxWeek 9 AssignmentContinue on with building your final applicatio.docx
Week 9 AssignmentContinue on with building your final applicatio.docx
 
Shared innovations in measurement and evaluation
Shared innovations in measurement and evaluationShared innovations in measurement and evaluation
Shared innovations in measurement and evaluation
 
Learning Health Care Systems
Learning Health Care SystemsLearning Health Care Systems
Learning Health Care Systems
 
Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1
Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1
Unit 1 - Concept of Health Economics (306.5 - HEHF) Part 1
 
National Juxtapositions in Healthcare Delivery and Quality
National Juxtapositionsin Healthcare Delivery and QualityNational Juxtapositionsin Healthcare Delivery and Quality
National Juxtapositions in Healthcare Delivery and Quality
 
Introduction to health economics for the medical practitioner
Introduction to health economics for the medical practitionerIntroduction to health economics for the medical practitioner
Introduction to health economics for the medical practitioner
 
The American Health Care Crisis - The Only Answer
The American Health Care Crisis - The Only AnswerThe American Health Care Crisis - The Only Answer
The American Health Care Crisis - The Only Answer
 

More from cheweb1

The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...
cheweb1
 
Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...
cheweb1
 
Withinfamily che presentation_200609
Withinfamily che presentation_200609Withinfamily che presentation_200609
Withinfamily che presentation_200609
cheweb1
 
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
cheweb1
 
Valuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patientValuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patient
cheweb1
 
Health Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for SponsorsHealth Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for Sponsors
cheweb1
 
Modeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policiesModeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policies
cheweb1
 
Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2
cheweb1
 
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertaintiesCost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
cheweb1
 
Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...
cheweb1
 
The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...
cheweb1
 
Adjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trialsAdjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trials
cheweb1
 
Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)
cheweb1
 
Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)
cheweb1
 
The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...
cheweb1
 
Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...
cheweb1
 
Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...
cheweb1
 
Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...
cheweb1
 
Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...
cheweb1
 
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
cheweb1
 

More from cheweb1 (20)

The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...
 
Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...
 
Withinfamily che presentation_200609
Withinfamily che presentation_200609Withinfamily che presentation_200609
Withinfamily che presentation_200609
 
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
 
Valuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patientValuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patient
 
Health Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for SponsorsHealth Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for Sponsors
 
Modeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policiesModeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policies
 
Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2
 
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertaintiesCost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
 
Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...
 
The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...
 
Adjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trialsAdjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trials
 
Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)
 
Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)
 
The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...
 
Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...
 
Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...
 
Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...
 
Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...
 
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
 

Recently uploaded

Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

Recently uploaded (20)

Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 

The longest-lasting, most popular, and yet most thoroughly discredited idea in the history of modern public policy: cost-effectiveness analysis

  • 1. The longest-lasting, most popular (and yet most thoroughly discredited) idea in the history of modern public policy Jeremy A. Lauer, PhD Economist Economic Analysis and Evaluation Health Systems Governance and Financing
  • 3. 1. Identify CEA’s connections to social choice and – enumerate the reasons explaining its durability. 2. Review the foundations of CEA and – clarify points of confusion. 3. Articulate an account of generalized CEA that differs from, and – is more liberal than, the standard version. 4. Reconcile disputes between generalized and incremental CEA, and – explain the source of controversies around threshold- based rules in decision-making. 5. Link the theory of generalized CEA to real-world decision making in a novel way. What I said I would do
  • 4. “The rapid and continuing growth of expenditures is a central issue in many policy decisions concerning the medical care system .... Policymakers, health professionals, and consumers are seeking ways to control this growth while simultaneously improving the quality of health care. Increasingly, the use of cost-effectiveness analysis ... is being advocated...” United States Congress Office of Technology Assessment. The Implications of Cost- Effectiveness Analysis of Medical Technology, Washington, DC, 1980. How to begin an article, 1980
  • 5. “It has become increasingly popular to carry out cost- effectiveness analyses in economic evaluations of healthcare programmes.” Karlsson G, Johannesson M. The decision rules of cost-effectiveness analysis. Pharmacoeconomics. 1996 Feb;9(2):113-20. How to begin an article, 1993
  • 6. “An increasing number of health-care systems, both public and private, such as managed-care organizations, are adopting results from cost-effectiveness analysis as one of the measures to inform decisions on allocation of health-care resources.” Eichler HG, Kong SX, Gerth WC, Mavros P, Jönsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health, 7(5):518-28, 2004. How to begin an article, 2004
  • 7. “… cost-effectiveness analysis (CEA) studies ... are routinely used around the globe to inform priority setting in health care and public health....” Cookson R, Mirelman AJ, Griffin S, Asaria M, Dawkins B, Norheim OF, Verguet S, J Culyer A. Using Cost-Effectiveness Analysis to Address Health Equity Concerns. Value Health, 20(2):206-212, 2017. How to begin an article, 2017
  • 8. “…decisions about whether to adopt technologies and services in publicly funded benefit packages, involve balancing health gains against the costs of the required resources: more and more frequently this is done in an explicit way, on the basis of analyses that build upwards from the biomedical evidence to create information to support decision makers in coming to judgements about value for money.” Lauer et al., in preparation, 2018 How to begin, again, 2018
  • 10. Perhaps this has an esoteric meaning
  • 11. Or possibly it’s just a goldfish story* *“It looks like new scenery, every time!”
  • 12. “I’m still where I was 40 years ago!” In few fields of science can one claim:
  • 13. Why is CEA so robust? 1. CEA expresses the idea that health is an intrinsic benefit (i.e. it counts in its own terms). – Important distinction w.r.t. its main competitor, benefit-cost analysis.
  • 14. 2. CEA is rational: – It respects individual autonomy. – It is objective (i.e. it uses scientific methods which are subject to continual open-source review). – It is impartial to persons. Why is CEA so robust?
  • 15. Two mainstreams in moral philosophy • Kant: Deontological concerns about rules of action: the stream MCDA is in. • Sidgwick: Utilitarian consequentialism: the stream CEA is in.
  • 16. 3. It belongs to a mainstream of moral philosophy: – the idea that actions should be judged by their outcomes, or consequences, and – that causal modelling can capture and organize knowledge about the relevant states of the world. Why is CEA so robust?
  • 17. 4. CEA solves a “coordination problem” – how do disparate groups of people organize themselves around a particular action or set of actions? – In economics, also called the problem of vertical integration. Why is CEA so robust?
  • 18. 1. United States Congress Office of Technology Assessment. The Implications of Cost-Effectiveness Analysis of Medical Technology, Washington, DC, 1980. 2. Drummond M, O’Brien B, Stoddart G, et al. Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press, 1987. 3. Canadian Coordinating Office for Health Technology Assessment. Guidelines for economic evaluation of pharmaceuticals, Ottawa, Canada: Canadian Coordinating Office for Health Technology Assessment, 1994. 4. Gold M, Siegel J, Russell L, et al. Cost-effectiveness in Health and Medicine. New York & Oxford: Oxford University Press, 1996. 5. World Health Organization. Guide to Cost-Effectiveness Analysis, Geneva: World Health Organization, 2003. 6. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied Methods of Cost-effectiveness Analysis in Health Care, Oxford, 2011. 7. Wilkinson T, Sculpher MJ, Claxton K, et al. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought. Value Health, 2016; 19: 921-928. Evolution is a fact
  • 19. Cost-effectiveness analysis was developed and refined in response to the demands of specific settings: – during the latter years of the 20th century – in the United States, Canada and England – [Refs 1, 2, 3, 4]. Beginnings matter
  • 20. There was a perception, in those days, on the part of decision makers, in those settings, that they had a mandate to improve the health of populations: through the regulation, financing or direct provision of health services. A la recherche du temps perdu…
  • 21. The 1980 report of the “Office of Technology Assessment of the United States Congress” cites over 650 references: – applying economic analysis to healthcare, – virtually all published in the 1970s, and – a substantial minority of which were published by government agencies. The hard progress of experience
  • 22. • In the early years of this century, staff at the WHO became interested in the application of cost-effectiveness analysis to health problems in developing countries [Ref 5]. • Hundreds (if not thousands) of scientific papers applying CEA to global health problems have since been published. New horizons
  • 23. • The technical basis of CEA evolved to support the needs of actors operating in a variety of jurisdictions. • For example, generalized cost effectiveness analysis (GCEA) was ostensibly created with the needs of lower income countries in mind: – not to solve the problem of the growing costs of medical care, – but to prioritize essential services for under-served populations. • Yet GCEA inevitably picked up themes from contemporary debates, in particular, those about health maximization and decision rules. Changes in practice bring changes in theory
  • 24. • Birch S, Gafni A. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? J Health Econ. 1992 Oct; 11(3):279-96. • Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. J Health Econ. 1993 Dec;12(4):459-67. Do decision rules maximize health?
  • 25. 1. So-called generalized cost-effectiveness analysis: – based on health maximization – (not thresholds). 2. So-called incremental (or marginal) cost- effectiveness analysis: – based on decision rules – involving thresholds. Two schools of thought
  • 28. GCEA: focus on portfolios
  • 29. Starting points and portfolios matter* *Acknowledgements to Richard Cookson for this clarification.
  • 30. • Interest in obtaining value for money for health in developing countries continues to grow: – the founding of the International Decision Support Initiative [Ref 7], and – the increasing use of CEA by a variety of domestic stakeholders and decision makers in developing and emerging economies. Global health, no longer public health
  • 31. • In the guidelines, over the years, CEA is given various justifications, often based on common sense principles. • However, CEA contains a cryptic sub-text, known only to a few… • CEA’s gnostic doctrine comes from duality theory for linear programming. The hidden story of CEA
  • 33. • WZ introduced the powerful idea of mathematical programming to CEA. • WZ also made CEA’s first* giant strategic blunder: – anchoring the notion of critical ratios in the mythology of CEA. • This resulted in lasting harms: – notably, controversies over ratio-centric cost- effectiveness thresholds. “No hay bien que por mal no venga” (every silver lining brings its cloud) *The second giant mistake was arguably the (self-defeating) “CHOICE GDP thresholds”.
  • 35. • CEA was not pre-destined to have a ratio-centric theory: – nothing pre-determined about this, – witness the many book-length guidelines. • CEA could equally have been developed around the concept of net benefit analysis, net cost analysis or even just opportunity cost analysis. • The latter is arguably the fundamental concept of CEA, not critical ratios. Different possible pasts for CEA
  • 36. 1. Lagrangian constrained optimization. 2. Duality theory in linear programming. • For our purposes, they’re the same: – Both involve optimal E/C ratios. • Because convex optimization, KKT theory, and mathematical programming are the primary superstructure of modern mathematical economics, we’ll use the latter form of the problem (duality). There are two sources of critical ratios
  • 37. The formulation of WZ is that of the primal of the linear-programming “knapsack problem”.
  • 38. The critical ratio comes from the dual of the knapsack problem (N.B. There’s no critical ratio in the primal knapsack problem.)
  • 39. Two great ideas that go great together
  • 40. The combination of: – Linear programming (e.g. the simplex method of 1947, without critical ratios), and – Duality for linear programming, with critical ratios). • These ideas go so well together that they usually come pre-mixed: Once you’ve seen it, you can’t unsee it
  • 41. Duality is hard (From the Preface to Nering ED, Tucker AW. Linear Programming and Related Problems. Boston, MA: Academic Press, 1993.)
  • 42. • Informal communications from George Dantzig: – Duality for linear programming conjectured by John von Neumann. – Proved by Albert Tucker, post-WWII at Princeton: • Some standard sources on duality are: – Dantzig et al., 1956 – Luenberger, 1973; – Nering and Tucker, 1993 – Bertsekas, 1995. Duality is new
  • 43. • Weinstein and Zeckhauser, 1973. • On the glass-half-full view, without WZ: – health economics would probably still be called medical economics, and – we’d possibly still be doing cost of illness studies, à la Dorothy Rice. • COI/CBA being the larger part of what predated the emergence of CEA in health economics. Duality is contemporary to the codification of CEA
  • 44. 1. Focus on optimal portfolios (WHO-CHOICE). 2. Redefine thresholds (York CHE). Two possible resolutions to CEA’s critical ratio problem
  • 45. York approach What's in, what's out : designing benefits for universal health coverage edited by Amanda Glassman, Ursula Giedion, and Peter C. Smith.
  • 46. • Are a summary measure of opportunity cost. • Are a measure of the marginal productivity of the health system. • Are a shortcut that avoids the need to quantify the costs and benefits of all feasible interventions. • Are a measure of the health people forgo when other options are funded than the ones that would benefit them. York thresholds are not ratios - they:
  • 47. CHOICE approach: efficient allocation doesn’t need ratios (There are no critical ratios in the primal knapsack.)
  • 48. Optimal portfolio of activities CVD Cancers Respiratory Conditions Diabetes Current portfolio of activities CVD Cancers Respiratory Conditions Diabetes “Magical rationalist” view of Efficient Allocation “Presto, change-o!”
  • 49. Current portfolio Optimal portfolio Health system factors Politics Affordability “Dismal realist” view of Efficient Allocation We may never get there…
  • 50. • A given optimal portfolio requires a particular type of health system, with a particular set of fixed assets. • Information about the contents of the portfolio allows actors in the health system to coordinate their choices. • Human resources and facilities, and logistics and supply networks, are fixed assets that are not replaceable, transferable or created in the short term. • Information about the optimal portfolio should influence most decisions about asset-specific investments. • This is one of the meanings of priority setting – determining which asset-specific investments to make. CHOICE view of Efficient Allocation
  • 51. Two kinds of decision-making (N.B. they are not strongly method dependent) • Localized, or incremental, decision-making: – Starts from current situation and adds things one at a time, – Often uses a threshold (of some kind). • Strategic, context-setting, decision-making: – Looks at many things at once, including the current portfolio, – Usually employs explicit maximization; sometimes uses a threshold. • When CEA is used to support localized decisions, we term it incremental cost-effectiveness analysis (ICEA). • When CEA is used to support strategic decisions, we call it generalized cost-effectiveness analysis (GCEA).